Related Experiment Video

Updated: May 5, 2026

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

6.8K

Incidence of Infective Endocarditis Post-TPVR with MELODY Valve in Pediatric Patients: A Systematic Review and

Sruthi Veldurthy1, Deepali Shrivastava2, Farhat Majeed3

  • 1Department of Pediatrics, Mediciti Institute of Medical Sciences, Telangana, India.

Current Cardiology Reviews
|September 18, 2024
PubMed

Insights

Infective endocarditis (IE) is a significant complication after transcatheter pulmonary valve replacement (TPVR) with the MELODY valve in children. This meta-analysis found a 17.7% incidence of IE, highlighting the need for further research and management strategies.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Biomedical Engineering

Background:

  • Infective endocarditis (IE) is a serious complication following transcatheter procedures, particularly Transcatheter Pulmonary Valve Replacement (TPVR).
  • The MELODY valve is frequently used in pediatric TPVR, necessitating an understanding of its associated IE risks.
  • Existing data on IE incidence post-pediatric TPVR with the MELODY valve requires synthesis.

Purpose of the Study:

  • To determine the incidence of IE in pediatric patients who underwent TPVR using the MELODY valve.
  • To conduct a systematic review and meta-analysis of existing literature on this topic.
  • To identify the clinical significance and statistical prevalence of IE post-MELODY valve TPVR.

Main Methods:

  • A comprehensive literature search was conducted across PubMed/MEDLINE, SCOPUS, and Science Direct.
  • Included studies focused on pediatric patients receiving TPVR with the MELODY valve.
  • Data on IE incidence, patient demographics, and time to IE occurrence were extracted and analyzed using Inverse Variance for pooled incidence estimation.

Main Results:

  • Four studies comprising 414 pediatric patients were analyzed.
  • The pooled incidence of IE post-TPVR with the MELODY valve was 17.70% (95% CI 3.84-31.55).
  • The mean time to IE development was 2.18 years (95% CI 0.35-4.01).

Conclusions:

  • IE is a clinically and statistically significant complication following TPVR with the MELODY valve in pediatric patients.
  • The findings underscore the importance of monitoring for IE in this population.
  • Further research is recommended to elucidate risk factors and optimize management strategies for IE post-pediatric TPVR.
Abstract

Keywords:
COVID-19.MELODY valveTPVRheart failureinfective endocarditispediatric population

More Related Videos

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

2.8K
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.5K

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.4K
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
686
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
873
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
360